PainChek

PainChek Receivables

The Accounts Receivable of PainChek (PCK.AX) as of Nov 11, 2026 is 446,000.00 AUD. In the previous year, Accounts Receivable was 355,200.00 AUD — a change of 25.56% (higher).

Receivables

446,000.00AUD

YoY

25.56%

Last updated:

Accounts Receivable of PainChek is 2025 446,000.00 AUD. Accounts Receivable of PainChek was 2024 355,200.00 AUD. It decreases by 25.56% higher compared to the previous year.

The PainChek Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
57,200.00 AUD
Jan 1, 2018
62,100.00 AUD
Jan 1, 2019
161,300.00 AUD
Jan 1, 2021
315,800.00 AUD
Jan 1, 2022
436,800.00 AUD
Jan 1, 2023
151,600.00 AUD
Jan 1, 2024
355,200.00 AUD
Jan 1, 2025
446,000.00 AUD
The PainChek Receivables history
YEARReceivablesYoY
446,000.00AUD+25.56%
355,200.00AUD+134.30%
151,600.00AUD-65.29%
436,800.00AUD+38.32%
315,800.00AUD+95.78%
161,300.00AUD+159.74%
62,100.00AUD+8.57%
57,200.00AUD+65.80%
34,500.00AUD-88.74%
306,300.00AUD+665.75%
40,000.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PainChek Stock analysis

What does PainChek do? PainChek Ltd. develops and commercializes mobile medical device applications, focusing on pain assessment for individuals unable to communicate with carers. The PainChek Universal combines the PainChek Application with the numerical rating scale (NRS), using artificial intelligence and facial recognition to detect pain in non-verbal patients. It provides a point-of-care solution that offers objectivity and consistency in pain assessments, supporting both non-verbal and self-reporting individuals through integrated tools. Healthcare providers and care facilities purchase PainChek Universal to enhance pain management protocols for patients with communication difficulties. The PainChek Application utilizes artificial intelligence and facial recognition technology to assess pain without relying on patient self-reporting, making it suitable for those with cognitive or physical impairments. PainChek Universal integrates the NRS for patients who can self-report, ensuring a comprehensive approach to pain evaluation across varying patient capabilities. This dual functionality allows healthcare professionals to apply consistent assessment standards regardless of a patient's ability to communicate. PainChek Ltd. generates revenue through the commercialization of its mobile medical device applications, specifically targeting healthcare providers and care facilities that require standardized pain assessment tools. The company’s products are designed to address the needs of patients who cannot communicate pain, thereby filling a critical gap in healthcare services. By offering a unified solution that combines AI-driven detection with traditional rating scales, PainChek Universal meets the demands of modern healthcare environments seeking objective and reliable pain management solutions. PainChek is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PainChek stock

Accounts Receivable of PainChek is 446,000.00 AUD in 2025.

Accounts Receivable of PainChek changed from 355,200.00 AUD to 446,000.00 AUD, representing a 25.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable PainChek since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's PainChek historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — PainChek

All Key Metrics — PainChek